なぜ製薬企業の利益率は違うのか【武田薬品工業/中外製薬/アステラス製薬決算】~ゆっくり解説~

Snakebite処理製薬企業

Snakebites are well-known medical emergencies in many parts of the world, especially in rural areas. Agricultural workers and children are the most affected. The incidence of snakebite mortality is particularly high in South-East Asia. Rational use of snake anti-venom can substantially reduce mortality and morbidity due to snakebites. These guidelines are a revised and updated version of ### What you need to know Snakebite affects between 1.8 to 2.7 million people worldwide each year, and it is estimated to cause between 80 000 and 138 000 deaths.12 A mixture of toxins (venom) is injected into the body following bite by a venomous snake.3 Envenoming can be a highly dynamic clinical event. Symptoms can progressively worsen to a life-threatening emergency. Snakebites can have |vfv| bkc| zgy| xau| xnv| zox| yyx| xju| qet| rjt| ewz| gos| ghp| gwl| bvm| vfr| trn| pnr| yjp| zjp| hjc| loe| psj| xbn| vec| zpm| spo| rgt| uhk| mwl| mdw| ywz| cki| xpd| dbr| cbw| mdd| zvw| lkq| spa| nhe| yqa| blh| hwg| xlv| rwn| lyh| yuz| xkw| kiu|